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Abstract
Knowledge gained in studies of genetic disorders is reported in a growing body of biomedical
literature containing reports of genetic variation in individuals that map to medical conditions and/
or response to therapy. These scientific discoveries need to be translated into practical applications
to optimize patient care. Translating research into practice can be facilitated by supplying clinicians
with research evidence. We assessed the role of existing tools in extracting answers to
translational research questions in the area of genomic medicine. We: evaluate the coverage of
translational research terms in the Unified Medical Language Systems (UMLS) Metathesaurus;
determine where answers are most often found in full-text articles; and determine common
answer patterns. Findings suggest that we will be able to leverage the UMLS in development of
natural language processing algorithms for automated extraction of answers to translational
research questions from biomedical text in the area of genomic medicine.
Introduction
Translational medicine attempts to connect basic
research to patient care, and is often referred to as
“bench to bedside.” For example, knowledge gained
from studying genetic disorders may aid in providing
more personalized care for patients [1]. This type of
knowledge is reported in a growing body of biomedical
literature containing reports of genetic variation in
individuals that map to medical conditions and/or
response to therapy. Current practice of medicine is
often reactive, where treatment does not occur unless
one becomes sick. Research institutes are envisioning a
shift in current medical practices to a more predictive,
personalized, preventative and participatory (P4 Medi-
cine) model [2,3]. Particularly in the context of genomic
medicine, we may be able to utilize knowledge reported
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model for practicing P4 medicine.
In the area of genomic medicine, we may ask the
question “given the vast amount of biomedical litera-
ture, how do we determine an answer to a translational
medicine-related question?” As a preliminary step
towards answering this question, we aim to determine
whether existing question answering methods and
biomedical informatics resources will be useful for
identifying and extracting answers to translational
research questions from biomedical text. The resources
we wish to investigate include the 2008AA UMLS
Metathesaurus and the MetaMap program.
The UMLS initiative [4] of the National Library of
Medicine aims to unify the medical vocabularies of
different medical knowledge sources, the UMLS Metathe-
saurus is a lexical framework for this integration. The
MetaMap Program (MM) [5] is a program that finds
UMLS concepts in the text and may be useful for
mapping biomedical text to concepts in the UMLS
Metathesaurus.
In the context of genomic medicine, the objectives for
our study were to: 1) Evaluate the UMLS Metathesaurus
coverage of translational research terminology; 2) Assess
the ability of the MM program to map translational
research terms from biomedical literature to the UMLS; 3)
Determine where answers to translational research ques-
tions are most often found (title, abstract, conclusion, etc.);
and 4) Determine common answer patterns to transla-
tional research questions.
Related work
In our research, we want to determine whether NLM tools
will be useful for extracting answers to translational
research questions from full-text articles in genomic
medicine. Information Extraction (IE) aims to provide a
user with facts and knowledge in an easy to understand
fashion. Our evaluation of answer patterns will be useful
for future development of IE algorithms. Related to this
endeavor is the Repository for Informed Decision Making
(RIDeM) project [6] that provides access to information
needed to support clinical decision-making. The current
prototype provides key facts relevant to a clinical question
or a patient’s record by matching clinical concepts extracted
from clinical text and salient points extracted from
MEDLINE abstracts. Clinical questions are captured using
a PICO-based framework [7], and MM and the UMLS are
utilized to extract facts from MEDLINE abstracts. Unlike
clinical question answering, providing answers to ques-
tions in the practice of genomic medicine is a relatively
new research area.
The interest to genomic information retrieval and
question answering was reflected in the Text Retrieval
Conference (TREC) Genomics Track evaluations [8]. The
2006 and 2007 evaluations focused on answering
genomics research questions by extracting answers
from full-text biomedical literature [9,10]. Questions
from the 2007 TREC Genomics Track evaluation were
derived based on biologists’ information needs, and
answers were lists of named entities of a given type. We
use the extracted answers from the 2007 TREC Genomics
Track evaluation as part of our gold standard dataset in
the presented research.
Methods
We had four objectives in the genomic medicine care
context: Objective 1 – Evaluate the UMLS Metathesaurus
coverage of translational research terminology; Objective
2 – Assess the ability of the MM program to map
translational research terms from biomedical literature
to the UMLS; Objective 3 – Determine where translational
research questions are most often found (title, abstract,
conclusion, etc.); and Objective 4 – Determine common
answer patterns to translational research questions.
C o m m o nm e t h o da c r o s so b j e c t i v e s
We used the 2007 TREC Genomics Track evaluation data
set [11] as our gold standard. Of the 29 questions
e x p l o r e di nt h i se v a l u a t i o n ,w ew e r ea b l et oi d e n t i f yf o u r
questions that were translational research related. These
questions include the following:
￿ <201> What [MUTATIONS] in the Raf gene are
associated with cancer?
￿ <216> What [GENES] regulate puberty in humans?
￿ <218> What [GENES] are implicated in regulating
alcohol preference?
￿ <224> What [GENES] are involved in the melano-
genesis of human lung cancers?
For each question we had a set of answer passages, full-text
(FT) documents for each of these, and associated answer
concept(s). Biologists participating in the 2007 TREC
Genomics Track evaluation assigned answer passages to
the appropriate answer concepts. An example answer
passage and associated answer concept is as follows:
Answer Passage: “Genetic heterogeneity of constitu-
tively activating mutations of the human luteinizing
hormone receptor in familial male-limited preco-
cious puberty”
Answer concept: “LUITENIZING HORMONE RECEP-
TOR (LHR) GENE”
T h eg o l ds t a n d a r dd a t as e tw a su s e dd i f f e r e n t l yf o re a c h
objective. For the first objective, we searched the UMLS
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UMLS concepts that matched, or were synonyms of, our
gold standard answer concepts were used for assessing
the accuracy of MM in our second objective. Our third
objective required that, for each gold standard FT
document, we search for, and note, the location of
associated answer passages. For our fourth objective, we
reviewed answer passages for each of our four questions
and identified common answer patterns. More details on
the gold standard data set follow.
Methods for objective 1
For our first objective, we evaluated how well the UMLS
covers translational research terminology. For each gold
standard answer, we manually identified two types of
matches, exact concept matches and partial concept
matches. A concept in the UMLS is considered an exact
match if it exactly matches, or is a synonym of, the gold
standard answer. For example, if our gold standard
concept is ADH and we identify Alcohol dehydrogenase
as a concept in the UMLS, we would consider this to be
an exact match because the two concepts are synon-
ymous. A concept is considered a partial match if an
exact match does not exist in the UMLS, but the major
concepts in a multiword concept exist. For example, if
our gold standard concept is GABAA RECEPTOR, #1
SUBUNIT, although there is no exact match in the UMLS,
we would identify the UMLS concept GABA-A Receptor
as a partial match. In our next objective, we compare our
UMLS match results to our MM retrieval results.
Methods for objective 2
For our second objective, we evaluate how well MM
maps translational research concepts from answer
passages to the UMLS Metathesaurus. For all questions,
the following UMLS semantic types were extracted as
potential answers: GENE OR GENOME;G ENETIC FUNCTION;
AMINO ACID,P EPTIDE, OR PROTEIN;R ECEPTOR;N UCLEOTIDE
SEQUENCE;A MINO ACID SEQUENCE;M OLECULAR SEQUENCE.
Lexicon-based methods (such as MM) require the
inclusion of all of these UMLS semantic types for two
reasons: 1) use of ambiguous names by paper authors,
and 2) UMLS multi-word sense coverage. An example of
the prior is use of “BRAF” for both the BRAF gene [GENE
OR GENOME] and BRAF protein, human [AMINO ACID,
PEPTIDE, OR PROTEIN]. Both terms are in the UMLS, but
fairly sophisticated context understanding is needed for
disambiguation. As an example to illustrate UMLS multi-
word sense coverage, even if an answer explicitly
mentions “cannabinoid receptor gene,” this concept is
not covered in the UMLS, and MM will break it up into
cannabinoid receptor [AMINO ACID,P EPTIDE, OR PROTEIN;
RECEPTOR] and Gene (Genes) [GENE OR GENOME].
In order to measure MM’s performance, we used a method
similar to that of a previous study where two types of
matches were identified for retrieved concepts [12]. We
identify each match as an exact or a partial match based on
matches found in the first objective. A concept is
considered an exact match if MM identifies a concept
found to be an exact match in the UMLS. We consider a
concept to be a partial match if the MM identifies a subset
of a multiword concept found to be a match in the UMLS.
For example, if our exact match in the UMLS is GPR54
gene and MM identifies G Protein-Coupled Receptor
Genes, we would consider it to be a partial match. In
addition to identifying exact and partial matches for our
MM results, we also did so for our baseline entity
extraction method. Our baseline entity extraction algo-
rithm retrieves all gene specific word shapes [13]. When the
baseline algorithm extracted a word shape that was
synonymous to our gold standard answer concept, it was
considered an exact match. For example, if our answer is
LUITENIZING HORMONE RECEPTOR (LHR) GENE, and
our baseline algorithm extracts “LHR”, we would consider
this an exact match. We considered our baseline data term
to be a partial match if it was not an exact match, but
matched a content-bearing word in a multiword gold
standard concept. For example, if our answer is B-
RAFV599E, and our baseline algorithm extracts “B-RAFV,”
we would consider this to be a partial match.
We compared our MM retrieval results to the results of
t h eb a s e l i n es e tt os h o wh o wt h ec o n t r o l l e dv o c a b u l a r y -
based MM algorithm compares to a baseline algorithm.
This comparison is accomplished by calculating precision
and recall measures. Precision (MetaMap/baseline) was
calculated as the number of gold standard individual
concepts with which our method found matches,
divided by the total number of concepts that the method
identified. Recall (MetaMap/baseline) was calculated as
the number of gold standard individual concepts
identified by the method, divided by the total number
of gold standard individual concepts. Details about our
comparison between the MM and baseline algorithms
may be found in the Result for objective 2 section. In
our next objective, we were interested in determining
where answers to translational research questions are
most often found in biomedical text.
Methods for objective 3
For the third objective we looked at where our gold
standard answer passages appeared in the associated FT
documents. Specifically, for each answer passage, we
made note of in which of the following FT section
answer concepts appeared: title; abstract; introduction;
discussion; results; references; no section titles; or other.
An answer may be included under “no section titles” if it
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section titles. Section “other” includes all section titles
that were not listed above. We then tallied up and
reported on the locations of our answers by FT section.
In our final objective, we looked at each gold standard
answer passage and recorded answer patterns for each.
Methods for objective 4
For our fourth objective, we determined common
patterns that exist in answer passages. To do so, we
first constructed a table of patterns for each of our four
questions. An example answer pattern is “MutationType
of GeneName OBSERVED in [SubjectType] with Pri-
maryCondition.” More details about answer patterns
may be found in the Results for objective 4 section.
In our evaluation, we discarded answer patterns only
occurring once, and tallied up all remaining patterns. We
refer to our top 10 grouped patterns as “common”
patterns. Negations occurred infrequently in the answer
passages; therefore they are not represented in our results
for this objective.
Results
Our initial aims were to determine how well transla-
tional research concepts are covered in the UMLS
Metathesaurus and how well MM functions as a
concept-identification tool within the domain of geno-
mic medicine. The goals of our later objectives were to
determine the location of answers within a FT article and
to identify common answer patterns. Results by objective
are described below.
Result for objective 1
Related to our first objective, we found that mutation types
were not covered in the UMLS Metathesaurus. Due to this
finding, we did not include the first question (<201> What
[MUTATIONS] in the Raf gene are associated with cancer?)
in our UMLS evaluation and MM assessment.
For a given question, answer concepts from our gold
standard data set often appeared more than once. For
example, in our answer set for <218>, there were 37 answer
passages with the concept CB1 (CANNABINOID RECEP-
TOR). Therefore, in our evaluation, we distinguish between
individual concepts and unique concepts. Our evaluation of
individual concepts includes all concepts even if they appear
in multiple answer passages. Where as with unique concepts,
answer conceptsmay only be counted once. In addition,for
each answer passage, there may be more than one concept
associated with an answer passage. We count individual
passagesanduniquepassagesasthesetsofconceptsassociated
with answer passages. Our total number of individual
passages includes all sets of concepts, even if the set appears
in multiple answer passages. Only unique sets of concepts
are counted in our evaluation of unique passages.F i g u r e1
illustrates the match granularity (partial, exact or no match)
of gold standard individual concepts, unique concepts,
individual passages and unique passages that are associated
with questions <216>, <218>, and <224>.
Overall, we found the UMLS coverage of answers to
questions of forms similar to the later three questions to
be very good. Approximately 92% of the unique answer
concepts and 80% of unique answer passages had
matches in the UMLS Metathesaurus.
Result for objective 2
We compared MM’s access to translational research
concepts to UMLS coverage of these concepts. We
found that MM identified 46% of the answers covered
i nt h eU M L S( S e eF i g u r e2 ) .I nf u r t h e re v a l u a t i o n ,w e
compared MM’s ability to identify answer concepts to
our baseline algorithm using precision/recall measures
(Figures 3 & 4).
The recall values of MM for questions <216>, <218> and
<224> were higher than that of the baseline algorithm,
although not statistically significant (P = 0.068). These
results suggest that we may need to explore ways to
improve MM’s access to translational research concepts.
One approach would be adjusting filtering options. Some
gene names may be suppressed by the MM program
because it is most often used in applications such as
RIDeM, where the user is primarily interested in answering
clinical questions. Additionally, it may be possible to
improve MM’s access by creating a customized view for the
genomic medicine domain. The Lister Hill NLP Content
View (LNCV) Project is currently creating such customized
views for other areas of research [14].
Figure 1
UMLS matches for questions 216, 218 and 224.U M L S
coverage of gold standard individual concepts, unique
concepts, individual passages and unique passages that are
associated with questions <216>, <218>, and <224>.
BMC Bioinformatics 2009, 10(Suppl 9):S8 http://www.biomedcentral.com/1471-2105/10/S9/S8
P a g e4o f8
(page number not for citation purposes)Result for objective 3
In evaluating the location of answers to translational
research questions within the FT documents, we found
that answers were located primarily in areas other than
the title and abstract (See Figure 5). Only 11% of the
answers were found in the title or abstract. This is in
contrast with answers to clinical questions, where as in
the case of the RIDeM project, the majority of the
answers may be found in MEDLINE abstracts. In the case
of answers to translational research questions, answers
were found most often in the Introduction section,
accounting for 26% of the answer passages.
Result for objective 4
Finally, we identified some common patterns that exist
in answer passages. Table 1 lists our top 10 ranked
patterns. Examples for common pattern components are
shown in Table 2. Examples for common relationships
captured in answer patterns are as follows:
￿ ASSOCIATED_WITH: significantly related to,
implicated in, associated with, maps to
￿ OBSERVED_IN: was identified in, were found in,
have been detected in, has been described in, were
first reported in
￿ AFFECTS: decreased, increased, diminishes, differ-
entially affects, reduces, code for
￿ CAUSES: causes, leads to, is thought to be
responsible for, promoted, resulted in
￿ HAS: displayed, reported, is reflected in, demon-
strate
￿ AFFECT_OF: innate differences of, reduction of,
effects of, stimulation of
￿ EVIDENCE_OF: reported that, our data suggest
that, our results have identified, additional studies
have confirmed that
It is evident from our observations that the degree of
certainty in answers differs. Additionally, gene names
and mutation types are often paired. In the future, we
Figure 2
MetaMap access (a) vs. UMLS coverage (b).P i ec h a r t s
to compare MetaMap's access to individual translational
research concepts and UMLS coverage of these concepts.
Figure 3
MetaMap precision and recall calculations. MetaMap
precision and recall calculations for questions <216>, <218>,
and <224>. The dark columns take only exact matches into
consideration. The light columns take both partial and exact
matches into consideration.
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order to refine and validate the identified patterns.
Discussion
Revisiting our original question of whether NLM tools
will be useful for extracting answers to translational
research questions, our answer is yes. It is clear from our
evaluation that both the UMLS Metathesaurus and the
MM program would be useful for identifying transla-
tional research terms. However, since the majority of the
answers are found in areas other than the title and
abstract of FT documents, Natural Language Processing
(NLP) and IE techniques are needed to find and extract
answers from biomedical text.
In this research, we encountered some limiting factors
that are areas for further research and may be taken into
consideration when developing NLP and IE algorithms.
For example, although we were able to maximize MM
recall by using the same UMLS semantic types for all
questions, this may also be viewed as a limiting factor
because it could partially explain low MM precision.
Therefore, in addition to exploring MM filtering options
described in the Result for objective 2 section, it may
also be useful to explore the use of individual semantic
types appropriate for each question type.
Another requirement for developing NLP and IE algo-
rithms for answering translational research questions is
illustrated in the Result for objective 1 section. Our
finding that certain mutation types (such as those
representative of answer concepts for question <201>)
are not covered in the UMLS, suggests a need to explore
coverage of mutations in other resources such as The
Human Gene Mutation Database [15].
Other limitations in our work are due to the need for a
specific translational research NLP challenge. Although
we found the data produced in the 2007 TREC Genomics
track evaluations to be valuable in this research, we were
only able to make use of a small portion of the questions
considered in this challenge. This need is further
exemplified in that TREC no longer holds a Genomics
track evaluation, and other related efforts do not focus
specifically on translational research. Such related
ongoing challenges include the i2b2 Shared-Task and
Workshop Challenges in Natural Language Processing
for Clinical Data Medical Extraction [16] and the
BioCreAtIvE (Critical Assessme n to fI n f o r m a t i o nE x t r a c -
tion systems in Biology) challenge evaluations [17].
Furthermore, although the patterns we identify in Objec-
tive 4 of our evaluation will be useful for developing NLP
and IE algorithms, the results of a translational research
NLP challenge will provide the greater number of question
answer pairs needed to identify answer patterns for
developing these algorithms. As patterns are established,
it may be useful to explore the extraction of identified
relationships between translational research concepts with
SemRep [18], an NLP system that relies on semantics and
domain knowledge contained in the UMLS.
Figure 4
Baseline precision and recall calculations. Baseline
algorithm precision and recall calculations for questions
<216>, <218>, and <224>. The dark columns take only
exact matches into consideration. The light columns take
both partial and exact matches into consideration.
Figure 5
Answer passage location. Pie chart representation of the
location of answers to translational research questions
within full-text articles.
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Our results suggest that further exploration of question
answering within the context of genomic medicine could
contribute to a move from the current reactive mode of
medical practice to a P4 Medicine model of practice. By
addressing the limitations we discuss in this article and
with proper use of NLP and IE techniques that leverage
NLM tools, we may be able to extract knowledge
reported in biological literature and facilitate question
answering in the practice of genomic medicine.
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Table 1: Top ranked answer patterns
Top pattern groups Number of
occurrences
Question(s)
represented
GeneName ASSOCIATED_WITH PrimaryCondition in [SubjectType] 31 216, 218, 224
GeneName MutatorType/MutationType AFFECTS PrimaryCondition in [SubjectType] 21 201, 218
GeneName AFFECTS PrimaryCondition in [SubjectType] 13 216, 218
GeneName OBSERVED_IN PrimaryCondition in [SubjectType] 12 201, 218
MutationType/EnvironmentalCondition of GeneName CAUSES PrimaryCondition in [SubjectType] 11 216, 218
MutationType in GeneName HAS PrimaryCondition 9 216, 218
GeneName MutationType/MutatorType in GeneName/MutationName OBSERVED_IN SubjectType Primary
Condition
9 201, 216
AFFECT_OF GeneName [in EnvironmentalCondition] on PrimaryCondition [SubjectType] 8 218
EVIDENCE_OF ASSOCIATION_BTWN GeneName and PrimaryCondition in [SubjectType] 5 218
EVIDENCE_OF GeneName in PrimaryCondition 5 218
Top 10 answer patterns occurring in the document set. Square brackets indicate optional entities.
Table 2: Common answer pattern components
Pattern component Examples Represented UMLS semantic types
GeneName BRAF; LHR; luteinizing hormone receptor; GPCRs; CB1
receptor; cannabinoid receptor; NMDA glutamate receptor;
CD117
[Gene or Genome]
[Amino Acid, Peptide, or Protein]
[Receptor]
MutationType B-RafV599E; V599EB-Raf; BRAFV599E; T1796A mutation;
Point mutations; homozygous mutations; null mutation
[Gene or Genome]
[Genetic Function]
[Cell or Molecular Dysfunction]
MutatorType antagonist, SR147778; antagonist, rimonabant (SR141716);
agonists, CP-55,940 and WIN-55,212-2; glycine-site
antagonists
[Organ or Tissue Function]
[Organic Chemical]
[Amino Acid, Peptide, or Protein]
[Pharmacologic Substance]
[Biologically Active Substance]
[Molecular Function]
EnvironmentalCondition paraventricular hypothalamic nucleus [Body Part, Organ, or Organ Component]
PrimaryConditon melanomas; papilary thyroid cancer; hypogonadism;
precocious puberty syndromes; ethonol consumption;
myeloid leukemia; germ cell tumors
[Neoplastic Process]
[Disease or Syndrome]
[Physiologic Function]
SubjectType human; Childhood; male patient; healthy boy; rats and mice [Human]
[Temporal Concept]
[Population Group]
[Patient or Disabled Group]
[Age Group]
[Mammal]
Examples for common answer pattern components and represented UMLS semantic types.
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